By contrast, in the second Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI 2) trial, comprising patients with type 2 diabetes mellitus and acute myocardial infarction (AMI), low MBL was not independently correlated with cardiovascular outcomes [8]. The gene discussed is INS; the disease is diabetes mellitus.